Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Hiroki Wakabayashi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hiroki Tsuchiya < Hiroki Wakabayashi < Hiroki Yamada  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000482 (2019) Hiroki Wakabayashi ; Hitoshi Kino ; Makoto Kondo ; Keiichi Yamanaka ; Masahiro Hasegawa ; Akihiro SudoEfficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature.
000784 (2018) Hiroki Wakabayashi [Japon] ; Takahiko Hamaguchi [Japon] ; Nobuto Nagao [Japon] ; Sho Kato [Japon] ; Takahiro Iino [Japon] ; Tomoki Nakamura [Japon] ; Akihiro Sudo [Japon]Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
001309 (2014) Hiroki Wakabayashi [Japon] ; Shinya Takigawa [Japon] ; Masahiro Hasegawa [Japon] ; Takuya Kakimoto [Japon] ; Kakunoshin Yoshida [Japon] ; Akihiro Sudo [Japon]Polyarticular late infection of total joint arthroplasties in a patient with rheumatoid arthritis treated with anti-interleukin-6 therapy.
001608 (2013) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa ; Yosuke Nishioka ; Yukari Minami ; Kusuki Nishioka ; Akihiro SudoClinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure.
001654 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa ; Yosuke Nishioka ; Akihiro Sudo ; Kusuki NishiokaWhich subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study.
001720 (2012) Hiroki Wakabayashi [Japon] ; Akihiro Sudo ; Yosuke Nishioka ; Masahiro Hasegawa ; Yukari Minami ; Kusuki NishiokaRepeat etanercept administration restores clinical response of patients with rheumatoid arthritis.
001C40 (????) Yoshiaki Matsushima [Japon] ; Akinobu Hayashi [Japon] ; Kento Mizutani [Japon] ; Makoto Kondo [Japon] ; Yasuo Nakai [Japon] ; Koji Habe [Japon] ; Yukie Yamaguchi [Japon] ; Yuji Kozuka [Japon] ; Hiroki Wakabayashi [Japon] ; Keiichi Yamanaka [Japon]Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Hiroki Wakabayashi" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Hiroki Wakabayashi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Hiroki Wakabayashi
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021